What Should I Tell My Healthcare Provider?
Talk with your healthcare provider prior to taking
Edarbi™ (
azilsartan medoxomil) if you have:
- Heart disease, including congestive heart failure (CHF)
- Kidney disease, such as kidney failure (renal failure)
- A history of high blood potassium (hyperkalemia) or have to use salt substitutes
- Diabetes
- A personal or family history of angioedema, which is swelling beneath the skin
- Any allergies, including to foods, dyes, or preservatives.
Also, let your healthcare provider know if you are:
- Pregnant or thinking of becoming pregnant
- Breastfeeding.
Make sure to tell your healthcare provider about all other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.
Specific Precautions and Warnings for Edarbi
Some warnings and precautions to be aware of prior to taking this medicine include the following:
- Medications similar to Edarbi can cause a potentially dangerous swelling below the surface of the skin, called angioedema, especially within the first month of treatment. Although this has not specifically been reported with Edarbi, it is still a good idea to watch for this problem. Stop taking Edarbi and seek immediate medical care if you develop any symptoms of angioedema, such as difficulty breathing or swelling of the face, eyes, lips, tongue, hands, or feet.
- You may experience dizziness or lightheadedness when you first start taking Edarbi as your blood pressure begins to lower. If you find yourself fainting, stop taking this drug and contact your healthcare provider as soon as possible.
- Sweating, dehydration (which could occur if you do not drink enough fluids), vomiting, and diarrhea could cause your blood pressure to lower to unsafe levels while taking Edarbi. Stay hydrated by drinking plenty of fluids, and let your healthcare provider know if you develop these symptoms.
- You should not use potassium supplements or salt substitutes that contain potassium without first checking with your healthcare provider. Edarbi may cause an increase in blood potassium levels (hyperkalemia), and taking products that contain potassium may further increase the level of potassium in your blood. People who have kidney disease or diabetes also have an increased risk for hyperkalemia with this medicine.
- If you are having any major surgery, make sure your healthcare provider knows you are taking Edarbi.
- This medicine may cause a decrease in kidney function, especially in people who have kidney disease or severe congestive heart failure (CHF). Your healthcare provider may choose to monitor your kidney function with a blood test while you are taking it. Contact your healthcare provider if you notice a decrease in urination or swelling in your hands, legs, ankles, or feet, which can be signs of kidney problems.
- Edarbi is a pregnancy Category D medication. This means that it may cause harm to an unborn child (see Edarbi and Pregnancy).
- It is not known whether Edarbi passes through breast milk. Therefore, if you are breastfeeding or plan to start, discuss this with your healthcare provider prior to taking this drug (see Edarbi and Breastfeeding).
HealthSavvy Sign In
|
